Detalhe da pesquisa
1.
Limitations of Murine Models for Assessment of Antibody-Mediated Therapies or Vaccine Candidates against Staphylococcus epidermidis Bloodstream Infection.
Infect Immun
; 84(4): 1143-1149, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26857577
2.
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.
Nat Commun
; 14(1): 1309, 2023 03 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36894558
3.
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.
Commun Med (Lond)
; 3(1): 75, 2023 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37237062
4.
Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B.
Curr Res Struct Biol
; 4: 96-105, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35469152
5.
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.
Nat Commun
; 13(1): 1699, 2022 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35361754
6.
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
Vaccine
; 40(9): 1289-1298, 2022 02 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35101265
7.
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza.
NPJ Vaccines
; 6(1): 153, 2021 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34916519
8.
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.
NPJ Vaccines
; 6(1): 61, 2021 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33875658
9.
Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting.
Vaccines (Basel)
; 8(4)2020 Dec 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33276673
10.
Proteomic profiling of precipitated Clostridioides difficile toxin A and B antibodies.
Vaccine
; 38(8): 2077-2087, 2020 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-31718902
11.
Deciphering the domain specificity of C. difficile toxin neutralizing antibodies.
Vaccine
; 37(29): 3892-3901, 2019 06 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31122858
12.
A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.
Clin Vaccine Immunol
; 22(7): 711-25, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25924765
13.
Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
J Med Microbiol
; 62(Pt 9): 1394-1404, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23518659